National Institutes of Health · United States

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics

Forecast — expected to open 31 Mar 2027

This is a forecast: the funder has announced the opportunity but it is not open yet; posting is expected around 31 Mar 2027 and the estimated deadline is 9 Jul 2027. Eligible applicant types include others (see text field entitled "Additional Information on Eligibility" for clarification), for profit organizations other than small businesses, nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education and 12 more.

Deadline: Estimated 9 Jul 2027 (not yet confirmed)
Opens: 31 Mar 2027
Grant amount: Not stated — see the official call
Funding rate: No mandatory cost sharing stated; funding percentage not stated
Cost sharing: Not required
Likely applicant types: SMEs / start-ups, Companies, Non-profits, Universities & research, Public bodies From source categories or programme rules; the call decides.
Funder: National Institutes of Health
Reference: PAR-28-059
Assistance listing: 93.865 Child Health and Human Development Extramural Research
Last checked: 15 Nov 2026

Open the official call ↗

About this call

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC), intends to renew and publish a Notice of Funding Opportunity (NOFO) to solicit applications to promote translational and clinical research in pregnant women, lactating women, infants, children, and adolescents to: (1) advance precision medicine through the development, testing, and implementation of novel tools, models, and other technologies; (2) discover and develop novel therapeutics or enhance the usage of existing drugs for safer and more effective medications; (3) enhance patient-provider communications about drug effectiveness and safety risks; and, (4) optimize the dissemination, implementation, sustainment, and scale-up of evidence-based interventions to these patient populations. The overall goal is to improve safe and effective precision therapeutics during pregnancy, lactation, and across childhood. Applications are not being solicited at this time.

Who can apply

Others (see text field entitled "Additional Information on Eligibility" for clarification)
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
City or township governments
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Independent school districts
State governments
Public housing authorities/Indian housing authorities
Small businesses
Private institutions of higher education
Native American tribal governments (Federally recognized)

Applicant categories are a starting point. The official call decides eligibility.

Topics

Health

How to apply

Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply: Not stated in the call text we hold — check the official page
Company stage: Not stated in the call text we hold — check the official page
Single applicant or consortium: Not stated in the call text we hold — check the official page
Where applicants must be based: Not stated in the call text we hold — check the official page
Where to apply: Not stated in the call text we hold — check the official page

Contact

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB) · Please contact via e-mail

Where these facts come from

Fact	Value	How we know	Taken from the source
Deadline	9 July 2027	official data field	15 Nov 2026
Amount per applicant	Unknown — not stated in the source we hold	unknown	—
Total budget	Unknown — not stated in the source we hold	unknown	—
Funding rate	No mandatory cost sharing stated; funding percentage not stated	read from the official text	15 Nov 2026
Who can apply	Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; Nonprofits that do not have a 501(c)(3) status with the IRS, other than…	official data field	15 Nov 2026
Where to apply	Unknown — not stated in the source we hold	unknown	—

Official sources

Official call page

Facts on this page come from the funder’s official data, taken on 15 Nov 2026. The funder's own documents, including later amendments, always take precedence.